NURS 5461 EXAM (MODULE 4, LESSON 2, NEUROLOGIC )
QUESTIONS AND 100% CORRECT VERIFIED/DETAILED
ANSWERS LATEST UPDATED 2025/2026 BEST GRADED A+ FOR
SUCCESS
MS management - CORRECT ANSWERS disabling symptoms
acute attacks- therapies to reduce inflammation and shorten duration
Long-term treatment focuses on reducing attacks, preventing new lesions, and slowing
disability
five therapies approved
MS management
nonpharmacologic therapies - CORRECT ANSWERS aggressive rehab after acute events
80% of patients use complementary or alternative medicine
yoga, cannabis extracts
MS management
pharm - CORRECT ANSWERS Symptomatic treatments; sometimes overused, probably
because the patient may feel better, but do not change disease course
usually relatively inexpensive
Disease Modifying Agents- have the potential to change the long-term sequelae of disease
progression
very expensive, long term medications
many side effects
Poor adherence is very common
Interferon-type medications
other immune modulators
MS management
symptoms- fatigue - CORRECT ANSWERS amantadine
,NURS 5461 EXAM (MODULE 4, LESSON 2, NEUROLOGIC )
QUESTIONS AND 100% CORRECT VERIFIED/DETAILED
ANSWERS LATEST UPDATED 2025/2026 BEST GRADED A+ FOR
SUCCESS
modafinil
MS management
urinary symptoms - CORRECT ANSWERS flomax
urodynamics, intermittent self-catheterization
MS management
muscle spasticity symptoms - CORRECT ANSWERS exercise/PT
muscle relaxants/ benzodiazepines
MS management
depression - CORRECT ANSWERS 50% lifetime
SSRIs
MS relapses - CORRECT ANSWERS not all need to be treated
assess gait and vision
Distinguish between new attack and pseudo attack
shorten the duration and severity of the attack by - corticosteroids (60-80 mg qd one week then
slow taper)
Gold standard: methylprednisolone: 1gm qd IV 3-5 days
not as much evidence for plasmapheresis, immunosuppression
pseudo attack- may have signs and symptoms, but from other source, like infection or stress
, NURS 5461 EXAM (MODULE 4, LESSON 2, NEUROLOGIC )
QUESTIONS AND 100% CORRECT VERIFIED/DETAILED
ANSWERS LATEST UPDATED 2025/2026 BEST GRADED A+ FOR
SUCCESS
Long term Therapies for MS - CORRECT ANSWERS no approved therapies for PPMS
2 recombinant interferon beta
RRMS- IFN-beta-1a (avonex)
Glatiramer acetate (Copaxone) myelin-like polypeptide
SPMS and RRMS- IFN-beta-1a (betaseron)
RRMS, SPMS, PRMS-mitoxantrone (Novantrone) anthracenedione with both anti-inflammatory
and immunomodulation properties
Most drugs require a premedication/titration regime
Guillian-Barre Syndrome (GBS)
summary - CORRECT ANSWERS GBS is an autoimmune disorder in which the body's
immune system attacks the peripheral nervous system
develops symmetrical muscle weakness and tingling sensations
starts in the legs and spreads to arms and upper body
Symptoms increase and sometimes the patient can be paralyzed
Symptoms develop within hours to weeks
can be life-threatening, requiring ventilator support
GBS- History and incidence - CORRECT ANSWERS first diganosied in 1916
1-100,00
QUESTIONS AND 100% CORRECT VERIFIED/DETAILED
ANSWERS LATEST UPDATED 2025/2026 BEST GRADED A+ FOR
SUCCESS
MS management - CORRECT ANSWERS disabling symptoms
acute attacks- therapies to reduce inflammation and shorten duration
Long-term treatment focuses on reducing attacks, preventing new lesions, and slowing
disability
five therapies approved
MS management
nonpharmacologic therapies - CORRECT ANSWERS aggressive rehab after acute events
80% of patients use complementary or alternative medicine
yoga, cannabis extracts
MS management
pharm - CORRECT ANSWERS Symptomatic treatments; sometimes overused, probably
because the patient may feel better, but do not change disease course
usually relatively inexpensive
Disease Modifying Agents- have the potential to change the long-term sequelae of disease
progression
very expensive, long term medications
many side effects
Poor adherence is very common
Interferon-type medications
other immune modulators
MS management
symptoms- fatigue - CORRECT ANSWERS amantadine
,NURS 5461 EXAM (MODULE 4, LESSON 2, NEUROLOGIC )
QUESTIONS AND 100% CORRECT VERIFIED/DETAILED
ANSWERS LATEST UPDATED 2025/2026 BEST GRADED A+ FOR
SUCCESS
modafinil
MS management
urinary symptoms - CORRECT ANSWERS flomax
urodynamics, intermittent self-catheterization
MS management
muscle spasticity symptoms - CORRECT ANSWERS exercise/PT
muscle relaxants/ benzodiazepines
MS management
depression - CORRECT ANSWERS 50% lifetime
SSRIs
MS relapses - CORRECT ANSWERS not all need to be treated
assess gait and vision
Distinguish between new attack and pseudo attack
shorten the duration and severity of the attack by - corticosteroids (60-80 mg qd one week then
slow taper)
Gold standard: methylprednisolone: 1gm qd IV 3-5 days
not as much evidence for plasmapheresis, immunosuppression
pseudo attack- may have signs and symptoms, but from other source, like infection or stress
, NURS 5461 EXAM (MODULE 4, LESSON 2, NEUROLOGIC )
QUESTIONS AND 100% CORRECT VERIFIED/DETAILED
ANSWERS LATEST UPDATED 2025/2026 BEST GRADED A+ FOR
SUCCESS
Long term Therapies for MS - CORRECT ANSWERS no approved therapies for PPMS
2 recombinant interferon beta
RRMS- IFN-beta-1a (avonex)
Glatiramer acetate (Copaxone) myelin-like polypeptide
SPMS and RRMS- IFN-beta-1a (betaseron)
RRMS, SPMS, PRMS-mitoxantrone (Novantrone) anthracenedione with both anti-inflammatory
and immunomodulation properties
Most drugs require a premedication/titration regime
Guillian-Barre Syndrome (GBS)
summary - CORRECT ANSWERS GBS is an autoimmune disorder in which the body's
immune system attacks the peripheral nervous system
develops symmetrical muscle weakness and tingling sensations
starts in the legs and spreads to arms and upper body
Symptoms increase and sometimes the patient can be paralyzed
Symptoms develop within hours to weeks
can be life-threatening, requiring ventilator support
GBS- History and incidence - CORRECT ANSWERS first diganosied in 1916
1-100,00
